We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
-$91.8M
Cap. Flow
-$238M
Cap. Flow %
-4.58%
Top 10 Hldgs %
22.29%
Holding
328
New
43
Increased
93
Reduced
100
Closed
61

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$38.2M
2
CCL icon
Carnival Corporation Ltd
CCL
+$37.7M
3
WBA
Walgreens Boots Alliance
WBA
+$35.3M
4
ICLR icon
Icon
ICLR
+$30.9M
5
CELG
Celgene Corp
CELG
+$29.8M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$63.8M
2
DHR icon
Danaher
DHR
+$50.4M
3
AZO icon
AutoZone
AZO
+$36.8M
4
AGN
Allergan plc
AGN
+$33.9M
5
BIIB icon
Biogen
BIIB
+$33.5M

Sector Composition

Rank Sector Weight
1 Technology 25.03%
2 Healthcare 24.38%
3 Financials 20.66%
4 Communication Services 10.61%
5 Consumer Discretionary 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLX
276
DELISTED
Hologic
HOLX
– –
-563,133
Closed -$18.6M
ISRG icon
277
Intuitive Surgical
ISRG
$128B
– –
-315,000
Closed -$17.7M
MRIN
278
DELISTED
Marin Software
MRIN
– –
-20,731
Closed -$5.47M
ORI icon
279
Old Republic International
ORI
$10.5B
– –
-200,000
Closed -$2.99M
PRGO icon
280
Perrigo
PRGO
$1.4B
– –
-12,000
Closed -$1.99M
PRQR icon
281
ProQR Therapeutics
PRQR
$244M
– –
-16,447
Closed -$360K
RVTY icon
282
Revvity
RVTY
$12.1B
– –
-63,800
Closed -$3.26M
SSYS icon
283
Stratasys
SSYS
$700M
– –
-20,390
Closed -$1.08M
TDC icon
284
Teradata
TDC
$2.8B
– –
-33,919
Closed -$1.5M
WDAY icon
285
Workday
WDAY
$36.4B
– –
-63,804
Closed -$5.39M
YELP icon
286
Yelp
YELP
$1.45B
– –
-259,537
Closed -$12.3M
ZG icon
287
Zillow
ZG
$7.32B
– –
-121,761
Closed -$4.07M
CLVS
288
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-8,704
Closed -$646K
MNDT
289
DELISTED
Mandiant, Inc. Common Stock
MNDT
– –
-69,922
Closed -$2.74M
CERN
290
DELISTED
Cerner Corp
CERN
– –
-39,745
Closed -$2.91M
XLRN
291
DELISTED
Acceleron Pharma
XLRN
– –
-14,049
Closed -$535K
HMSY
292
DELISTED
HMS Holdings Corp.
HMSY
– –
-97,798
Closed -$1.51M
AGN
293
DELISTED
Allergan plc
AGN
– –
-114,000
Closed -$33.9M
ALDR
294
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-128,461
Closed -$3.71M
UPL
295
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
– –
-720,439
Closed -$11.3M
ULTI
296
DELISTED
Ultimate Software Group Inc
ULTI
– –
-75,983
Closed -$12.9M
SGYP
297
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-183,119
Closed -$846K
CALD
298
DELISTED
Callidus Software, Inc.
CALD
– –
-844,370
Closed -$10.7M
YHOO
299
DELISTED
Yahoo Inc
YHOO
– –
-83,736
Closed -$3.72M
RLYP
300
DELISTED
RELYPSA INC COM
RLYP
– –
-18,110
Closed -$653K
9 10 11
12
13

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Polar Capital held 328 positions worth $5.2B, down 1.7% from $5.29B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital withdrew a net $238M in Q2 2015, closing 61 positions and reducing 100 holdings. Its most notable exit was Danaher, an estimated $50.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital opened a new position in Stryker worth $38.5M.

  • Polar Capital's largest Q2 2015 buy was Stryker: 402,973 shares worth $38.5M.
  • Polar Capital added most to Celgene Corp in Q2 2015, an estimated $29.8M increase.
  • Polar Capital's biggest Q2 2015 reduction was Merck, cutting an estimated $63.8M.
  • Polar Capital fully exited Danaher in Q2 2015, selling an estimated $50.4M.
  • Polar Capital's ten largest holdings make up 22% of its $5.2B portfolio in Q2 2015.
  • Polar Capital opened 43 new positions and closed 61 in Q2 2015.
  • Polar Capital's portfolio value fell 1.7% quarter-over-quarter to $5.2B.

Based on Polar Capital's 13F filing for Q2 2015, filed 14 Aug 2015.